News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice
Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made between a pregnant woman and her doctor. “The data on the COVID vaccine booster in pregnant women is a mixed set of data,” Makary said in an interview. “Now, I think the decision should be between a doctor and a pregnant woman.”
U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
The FDA is proposing to limit annual COVID-19 ... by Novavax Inc. Vaccine manufacturers have said that because COVID vaccines change annually to target specific strains of the virus, the ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor who Trump tapped to lead the FDA, clarified the recently changed ...
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback